An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans †

Lilach Steiner, David Bibi, Avia Merenlender Wagner, Pavel Farkas, Safra Rudnick-Glick, Pippa Loupe, Hussein Hallak

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans †'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science